Veru is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mitchell S. Steiner, with a market cap of $39.0M.
Common questions about Veru
Veru is scheduled to report earnings for Q2 2026 on May 7, 2026.
Veru has approximately 233 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.